Beyond Brexit: What Now for Clinical Supply Services across Europe?

Date: 30 April  |  Time: 3PM London/10AM New York

Watch Now for FREE ON24

Already Registered?

If you have previously registered for this event, please login below:

Register your details below





Visit our privacy policy for more information about our services, how we may use and process your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

After three years of Brexit withdrawal negotiations, the UK is officially no longer a member of the European Union. Clinical sponsors with active and planned studies in the EU and UK can be reassured that the UK will remain part of the current trade arrangements, customs union and single market until the end of the transition period on December 31, 2020. Although future change is certain after the transition period ends, clinical sponsors now have a clearer vision of what strategic options are available so that they may continue to run trials in the UK and EU. This panel presentation will explore the early analysis of potential Brexit challenges that sponsors face and the strategic solutions that can support sponsors in a post-Brexit world.

Moderated by

Paul Ingram, PhD,

Global Director, Strategic Development and Innovation, Catalent

Paul’s 25 years career has focused on medical device and pharmaceutical research and development. Paul holds a Ph.D. in pharmaceutical development from Strathclyde University in Glasgow. He has over 15 years of experience in clinical supplies working both in Phase 1 units and trial supplies service companies including Quintiles (Aptuit), Fisher Clinical and Catalent.

Expert Panelists

Rognvald Lamb,

Director, Transportation Services, Clinical Supply Services, Catalent

Jan Philips,

Quality Director, Catalent

Karen Anglesea,

Manager, Storage and Distribution, Catalent

Key Learning Objectives

  • Understand the current status of Brexit and what is next
  • Understand the impact of Brexit on the supply chain and clinical supplies in particular
  • Explore strategic options for managing clinical supplies in the UK and Europe

Audience

  • Consultant
  • R&D Management
  • Clinical Supply Management
  • Clinical Operations
  • Supply Chain Operations
  • Clinical Logistics
  • Procurement & Sourcing
  • Clinical Trial Consultants
  • CROs
business review webinar